Outcome Of Allopurinol Or Febuxostat Treatment In Gout Patients Naive To Urate-Lowering Therapy

被引:0
|
作者
Khanna, Puja [1 ]
Hatoum, Hind [2 ]
Lin, Swu-Jane [2 ]
Shiozawa, Aki [3 ]
Akhras, Kasem [3 ]
Khanna, Dinesh [1 ]
机构
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[2] Univ Illinois, Chicago, IL USA
[3] Takeda Pharmaceut Int Inc, Deerfield, IL USA
来源
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2009
引用
收藏
页码:S857 / S857
页数:1
相关论文
共 50 条
  • [21] Comparison of persistence rates between allopurinol and febuxostat as first-line urate-lowering therapy in patients with gout: an 8-year retrospective cohort study
    Kim, Aran
    Kim, Yunkyung
    Kim, Geun-Tae
    Ahn, Eunyoung
    So, Min Wook
    Lee, Seung-Geun
    CLINICAL RHEUMATOLOGY, 2020, 39 (12) : 3769 - 3776
  • [22] Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Chang, Chia-Ling
    Yang, Chen-Chang
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (12): : 2599 - 2606
  • [23] Letter to the editor regarding "urate-lowering therapy for patients with gout on hemodialysis"
    Tsai, Yung-Shun
    Lee, Yung-Heng
    Ko, Meng-Yu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (01) : 177 - 178
  • [24] Serum Urate-Lowering Effectiveness of Febuxostat Compared with Allopurinol and Switching to Febuxostat From Allopurinol In the Real-World Setting.
    Pandya, Bhavik J.
    Pinsky, Brett W.
    Rey, Gabriel Gomez
    Singh, Jasvinder A.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S350 - S350
  • [25] Effect of Urate-Lowering Therapy on Radiographic Changes in Gout Patients.
    Lee, Seulkee
    Kim, Inyoung
    Jeong, Hyemin
    Hwang, Jiwon
    Kim, Hyungjin
    Lee, Jaejoon
    Cha, Hoon-Suk
    Koh, Eun-mi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S77 - S77
  • [26] OPTIMISTIC STATUS ASSOCIATES WITH COMPLIANCE TO URATE-LOWERING THERAPY IN GOUT PATIENTS
    Zhao, W.
    Huang, Z.
    Huang, Y.
    Liu, Y.
    Liu, X.
    Zhong, Z.
    Chen, S.
    Li, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 457 - 458
  • [27] Urate-lowering treatment and risk of total joint replacement in patients with gout
    Kuo, Chang-Fu
    Chou, I-Jun
    See, Lai-Chu
    Chen, Jung-Sheng
    Yu, Kuang-Hui
    Luo, Shue-Fen
    Hsieh, Ao-Ho
    Zhang, Weiya
    Doherty, Michael
    RHEUMATOLOGY, 2018, 57 (12) : 2129 - 2139
  • [28] Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England
    Kuo, Chang-Fu
    Grainge, Matthew J.
    Mallen, Christian
    Zhang, Weiya
    Doherty, Michael
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (24): : 2684 - 2686
  • [29] Improvement of urate-lowering treatment of gout by international recommendations
    Bardin, T.
    Nguyen, Q. D.
    Resche-Rigon, M.
    Richette, P.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2022, 206 (07): : 825 - 830
  • [30] Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
    Becker, Michael A.
    Schumacher, H. Ralph
    MacDonald, Patricia A.
    Lloyd, Eric
    Lademacher, Christopher
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (06) : 1273 - 1282